Minerva Neurosciences, Inc. (NERV)
NASDAQ: NERV · Real-Time Price · USD
4.090
-0.190 (-4.44%)
At close: Jul 29, 2026, 4:00 PM EDT
4.090
0.00 (0.00%)
After-hours: Jul 29, 2026, 4:10 PM EDT

Minerva Neurosciences Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.

Total Valuation

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jul '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
1911741643834
Market Cap Growth
1178.84%1020.51%-63.90%406.53%-75.20%-65.76%
Enterprise Value
172.48156.5254.0684.0146.0339.7
Last Close Price
4.094.022.226.151.596.41

Price Ratios

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jul '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
PE Ratio
--11.68---
PB Ratio
--1.24-0.60-1.51-0.424.29

Financial Efficiency

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jul '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Debt / Equity Ratio
-0.24-0.44-2.34-2.88-3.688.32
Net Debt / Equity Ratio
0.070.16-1.50-1.44-1.870.69
Net Debt / EBITDA Ratio
0.651.48-1.77-1.78-1.49-0.12
Net Debt / FCF Ratio
1.221.66-1.97-2.77-1.52-0.22
Quick Ratio
17.4435.987.5712.2826.2721.59
Current Ratio
17.6536.287.8512.5729.1522.07
Return on Equity (ROE)
13.77%363.42%-5.31%123.78%532.99%-164.60%
Return on Assets (ROA)
-29.03%-22.36%-46.46%-41.29%-38.17%-64.99%
Return on Invested Capital (ROIC)
-30.09%-23.24%-49.73%-43.11%-75.14%-214.81%
Return on Capital Employed (ROCE)
-30.10%-23.24%-49.73%-43.11%-39.42%-70.46%

Yields

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jul '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Earnings Yield
--8.56%---
Buyback Yield / Dilution
-131.67%-11.75%-16.41%-21.16%-0.56%-4.41%
Total Shareholder Return
-131.67%-11.75%-16.41%-21.16%-0.56%-4.41%
SEC Filings: 10-K · 10-Q